BioSpace News Archive

Electromedical Technologies, Inc., a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that its annual product special offer is generating solid demand and interest, which is typical of this holiday season cyber campaign.

Immuron’s Hyper-immune Bovine Colostrum, used to manufacture Travelan® and Protectyn®, demonstrated antiviral activity against the SARS-CoV-2/COVID-19 virus in laboratory studies.

Controlant, a leader in real-time supply chain monitoring and visibility technologies for heavily regulated industries, such as pharmaceuticals & life sciences and food & beverage sectors, today announced it is providing monitoring and Supply Chain Visibility services to Pfizer, in relation to the delivery of Pfizer’s mRNA-based Pfizer-BioNTech COVID-19 vaccine’s global distribution.

Greenwich LifeSciences, Inc. announced that it has entered into an option agreement with Westport Bio, exercisable at the sole discretion of the Company, to in-license a pre-clinical coronavirus vaccine program that is currently at the stage of pre-clinical animal testing.

Eli Lilly and Company (NYSE: LLY) and Prevail Therapeutics Inc. (NASDAQ: PRVL) today announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share in cash (or an aggregate of approximately $880 million)

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI) effective prior to the market open on Monday, December 21, 2020.

Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces it has been invited to present about the performance of two types of its test-workflow Quality Assessment Products (QAPs™) at the 2020 virtual Scientific Meeting and Clinical Lab Expo of the American Association of Clinical Chemistry (AACC) taking place December 13-17, 2020.

Eli Lilly and Company (NYSE: LLY) today announced its 2021 financial guidance, highlighted by volume-based revenue growth, increased investment in research and development, operating margin expansion and strong earnings performance.

Audacious Inquiry (Ai), an industry leader in connected care, and Surescripts, the nation’s leading health information network, are combining forces to improve patient care management during declared disasters by integrating patient medication history data into Ai’s PULSE Enterprise, a platform that allows providers to access medical information for patients in times of emergency.

Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., presented her paper, “Targeting Increased Levels of Neurotoxic Proteins in Down Syndrome, Alzheimer’s and Parkinson’s Animals Normalized Axonal Transport, Cognition and Function,”